Sandoz’ Saynor Insists On Value Of ‘Pure Play’ Approach

CEO Also Discusses US Leadership Change And Importance Of Japan

 
• By Dave Wallace

Sandoz is benefiting from its focus on a “pure play” generics and biosimilars model that is unique among its peers, CEO Richard Saynor tells Generics Bulletin in an exclusive interview.

Richard Saynor
Saynor says Sandoz’ ‘pure play’ strategy sets it apart from its peers • Source: Sandoz

More from Strategy

More from Business